| 7001 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T146 | ECGU000146 | 0.18 |
| 7002 | CDC37/SNX9 ratio | GCST90313936 | 0.18 |
| 7003 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498651 | 0.18 |
| 7004 | Monounsaturated fatty acids levels (UKB data field 23447) | GCST90269544 | 0.18 |
| 7005 | Free cholesterol levels in very large HDL | GCST90093008 | 0.18 |
| 7006 | C9 Carnitine levels in chronic kidney disease | GCST90257682 | 0.18 |
| 7007 | HMOX1 levels | GCST90469465 | 0.18 |
| 7008 | RNASE1 levels | GCST90470476 | 0.18 |
| 7009 | PVR levels | GCST90470394 | 0.18 |
| 7010 | Benign neoplasm of eye (PheCode 224) | GCST90475626 | 0.18 |
| 7011 | Urolithiasis | GCST90018715 | 0.18 |
| 7012 | Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452) | GCST90269549 | 0.18 |
| 7013 | Left ventricular ejection fraction | GCST90268125 | 0.18 |
| 7014 | XIAP levels | GCST90471083 | 0.18 |
| 7015 | Monounsaturated fatty acid levels | GCST90502036 | 0.18 |
| 7016 | Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers) | FING00000766 | 0.18 |
| 7017 | Eye problems/disorders - Cataract | Eyesight | UKBB00000230 | 0.18 |
| 7018 | Number of correct matches in round | Pairs matching | UKBB00000532 | 0.18 |
| 7019 | Triglycerides in small HDL (UKB data field 23578) | GCST90269675 | 0.18 |
| 7020 | NELL1 levels | GCST90470026 | 0.17 |
| 7021 | Saturated fatty acids levels | GCST90502186 | 0.17 |
| 7022 | ROR1/THBD ratio | GCST90315786 | 0.17 |
| 7023 | Colorectal cancer (PheCode 153) | GCST008372 | 0.17 |
| 7024 | GRP levels | GCST90469406 | 0.17 |
| 7025 | IDP dMRI ProbtrackX ICVF cgc r | GCST90004380 | 0.17 |
| 7026 | Behenoyl dihydrosphingomyelin (d18:0/22:0) levels | GCST90200059 | 0.17 |
| 7027 | CD84/GP6 ratio | GCST90313914 | 0.17 |
| 7028 | EFCAB14 levels | GCST90469076 | 0.17 |
| 7029 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285 | ECGA000285 | 0.17 |
| 7030 | Takes medication for prostate cancer? | GCST90475187 | 0.17 |
| 7031 | Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivity | GCST90302710 | 0.17 |
| 7032 | N-acetylcarnosine levels | GCST90199926 | 0.17 |
| 7033 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161 | ECGU000161 | 0.17 |
| 7034 | TYRO3 levels | GCST90470997 | 0.17 |
| 7035 | Erectile dysfunction | GCST006956 | 0.17 |
| 7036 | Total esterified cholesterol levels | GCST90500034 | 0.17 |
| 7037 | wg rh intensity-contrast lateralorbitofrontal | GCST90003838 | 0.17 |
| 7038 | LY6G6C levels | GCST90241830 | 0.17 |
| 7039 | GP2 levels | GCST90469382 | 0.17 |
| 7040 | HippSubfield rh volume presubiculum-body | GCST90002697 | 0.17 |
| 7041 | IDP dMRI TBSS ICVF Anterior corona radiata R | GCST90004349 | 0.17 |
| 7042 | Other chronic obstructive pulmonary disease | Chronic lower respiratory diseases | UKBB00000604 | 0.17 |
| 7043 | Osteoporosis (PheCode 743.1) | GCST90476384 | 0.17 |
| 7044 | SMPD3 levels | GCST90470685 | 0.17 |
| 7045 | OMD/SPP1 ratio | GCST90315586 | 0.17 |
| 7046 | COL1A1/SOST ratio | GCST90314172 | 0.17 |
| 7047 | Cystatin C production | GCST90267986 | 0.17 |
| 7048 | CD99/CD99L2 ratio | GCST90313923 | 0.17 |
| 7049 | CR1 levels | GCST90468851 | 0.17 |
| 7050 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163 | ECGU000163 | 0.17 |
| 7051 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418 | ECGU000418 | 0.17 |
| 7052 | SH3GLB2 levels | GCST90470621 | 0.17 |
| 7053 | DTI autoptx MD slf l tract | GCST90385241 | 0.17 |
| 7054 | Milk type: Skimmed, semi-skimmed or full cream (UKB data field 1418) | GCST90133005 | 0.17 |
| 7055 | Concentration of medium VLDL particles (UKB data field 23502) | GCST90269599 | 0.17 |
| 7056 | WFIKKN2 levels | GCST90422127 | 0.17 |
| 7057 | Systolic blood pressure, manual reading | Blood pressure | UKBB00000810 | 0.17 |
| 7058 | PM: initial answer - Orange circle| Prospective memory | UKBB00000652 | 0.17 |
| 7059 | Cholesterol to Total Lipids in Medium HDL percentage | GCST90498519 | 0.17 |
| 7060 | CCL28 levels | GCST90468580 | 0.17 |
| 7061 | Phospholipid levels in very small VLDL | GCST90093036 | 0.17 |
| 7062 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668505 | 0.17 |
| 7063 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70 | ECGA000070 | 0.17 |
| 7064 | T1 CAT volume L CingulateGyrusanteriordivision | GCST90384056 | 0.17 |
| 7065 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T137 | ECGU000137 | 0.17 |
| 7066 | Right-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302840 | 0.17 |
| 7067 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T143 | ECGA000143 | 0.17 |
| 7068 | Leisure/social activities - Sports club or gym | Social support | UKBB00000402 | 0.17 |
| 7069 | GALNT2 levels | GCST90469296 | 0.17 |
| 7070 | C4 levels | GCST90281042 | 0.17 |
| 7071 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134 | ECGU000134 | 0.17 |
| 7072 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T245 | ECGA000245 | 0.17 |
| 7073 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159 | ECGU000159 | 0.17 |
| 7074 | WFDC12 levels | GCST90471073 | 0.17 |
| 7075 | Prescriptions - antispasmodic | UKBB00000666 | 0.17 |
| 7076 | IDP dMRI TBSS ISOVF Anterior corona radiata L | GCST90004500 | 0.17 |
| 7077 | TNFSF12/TNFSF13 ratio | GCST90315941 | 0.17 |
| 7078 | MITD1/RHOC ratio | GCST90315453 | 0.17 |
| 7079 | T1 FreeSurfer DK lh MeanThickness thickness | GCST90385656 | 0.17 |
| 7080 | SSC-A on plasmacytoid Dendritic Cell | GCST90002072 | 0.17 |
| 7081 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498007 | 0.17 |
| 7082 | Spleen iron concentration | GCST90101831 | 0.17 |
| 7083 | ITGB5/VSIR ratio | GCST90315235 | 0.17 |
| 7084 | THBD levels | GCST90470853 | 0.17 |
| 7085 | DTI TBSS FA External capsule R | GCST90384412 | 0.17 |
| 7086 | Free cholesterol in very large HDL | GCST90500383 | 0.17 |
| 7087 | Pork consumption | GCST90132999 | 0.17 |
| 7088 | Diacylglycerol_34:1_[M+H-H2O]1+ levels | GCST90060179 | 0.17 |
| 7089 | CRNN levels | GCST90468869 | 0.17 |
| 7090 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268 | ECGU000268 | 0.17 |
| 7091 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82 | ECGU000082 | 0.17 |
| 7092 | Duration screen displayed | Prospective memory | UKBB00000201 | 0.17 |
| 7093 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T89 | ECGA000089 | 0.17 |
| 7094 | Phenylalanine levels | GCST90092936 | 0.17 |
| 7095 | Obstructive chronic bronchitis | respiratory | UKBB00000546 | 0.17 |
| 7096 | IDO1 levels | GCST90241490 | 0.17 |
| 7097 | BCAM/CLEC14A ratio | GCST90313470 | 0.17 |
| 7098 | PSRC1/SMAD1 ratio | GCST90315741 | 0.17 |
| 7099 | IL6R levels | GCST90469602 | 0.17 |
| 7100 | Osteoarthritis (self-reported) | GCST005811 | 0.17 |
| 7101 | MDGA1 levels | GCST90469875 | 0.17 |
| 7102 | Lymphocyte count | GCST90002317 | 0.17 |
| 7103 | Cholesterol to total lipids in large LDL percentage (UKB data field 23615) | GCST90269712 | 0.17 |
| 7104 | GFER/VASH1 ratio | GCST90314922 | 0.17 |
| 7105 | Monocyte count | Blood count | UKBB00000479 | 0.17 |
| 7106 | Brugada syndrome | GCST90086158 | 0.17 |
| 7107 | FETUB levels | GCST90469215 | 0.17 |
| 7108 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T153 | ECGU000153 | 0.17 |
| 7109 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T272 | ECGA000272 | 0.17 |
| 7110 | PM: initial answer - Blue square | Prospective memory | UKBB00000651 | 0.17 |
| 7111 | CRHBP/TREM2 ratio | GCST90314260 | 0.17 |
| 7112 | 5alpha-androstan-3beta,17beta-diol monosulfate (2) levels | GCST90199855 | 0.17 |
| 7113 | APOB/APOA1 ratio | GCST90092810 | 0.17 |
| 7114 | rfMRI connectivity (ICA100 edge 951) | GCST90005804 | 0.17 |
| 7115 | Omega-6 fatty acids to omega-3 fatty acids ratio | GCST90499199 | 0.17 |
| 7116 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T287 | ECGA000287 | 0.17 |
| 7117 | Triglycerides to total lipids ratio in large LDL | GCST90092867 | 0.17 |
| 7118 | IDP dMRI TBSS L2 Superior cerebellar peduncle R | GCST90004135 | 0.17 |
| 7119 | F11R/TMSB10 ratio | GCST90314729 | 0.17 |
| 7120 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498944 | 0.17 |
| 7121 | SDHB levels | GCST90470561 | 0.17 |
| 7122 | MSTN/RGMA ratio | GCST90315504 | 0.17 |
| 7123 | DTI autoptx L3 fmi tract | GCST90385204 | 0.17 |
| 7124 | Chronic venous insufficiency [CVI] (PheCode 456) | GCST90476016 | 0.16 |
| 7125 | FLT3 levels | GCST90469251 | 0.16 |
| 7126 | Cholesteryl esters to total lipids ratio in medium HDL | GCST90092895 | 0.16 |
| 7127 | FGFR2/TGFBR2 ratio | GCST90314813 | 0.16 |
| 7128 | UFC1 levels | GCST90243245 | 0.16 |
| 7129 | Ulcerative colitis | GCST90018713 | 0.16 |
| 7130 | SPINK5/SPINT1 ratio | GCST90315877 | 0.16 |
| 7131 | aparc-a2009s lh area G-parietal-sup | GCST90003323 | 0.16 |
| 7132 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482 | ECGA000482 | 0.16 |
| 7133 | CLIP2/DNAJA2 ratio | GCST90314127 | 0.16 |
| 7134 | DRG2/SEMA4D ratio | GCST90314554 | 0.16 |
| 7135 | aparc-Desikan rh area isthmuscingulate | GCST90003116 | 0.16 |
| 7136 | PTPN6/YES1 ratio | GCST90315750 | 0.16 |
| 7137 | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | GCST90200103 | 0.16 |
| 7138 | Left-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302750 | 0.16 |
| 7139 | Principal component-derived dietary pattern 2 | GCST90133007 | 0.16 |
| 7140 | Facial wrinkles (under eye) | GCST90094903 | 0.16 |
| 7141 | Total triglycerides levels | GCST90092992 | 0.16 |
| 7142 | FKBP5/TBCC ratio | GCST90314849 | 0.16 |
| 7143 | IFNG levels | GCST90469515 | 0.16 |
| 7144 | Neutrophil count | GCST004629 | 0.16 |
| 7145 | CREG1 levels | GCST90468857 | 0.16 |
| 7146 | Neutrophil count | GCST90002351 | 0.16 |
| 7147 | Average diameter for LDL particles | GCST90498458 | 0.16 |
| 7148 | IDP dMRI ProbtrackX L3 str r | GCST90004324 | 0.16 |
| 7149 | T1 FreeSurfer BA lh BA2 exvivo volume | GCST90385534 | 0.16 |
| 7150 | FUT8/TNFSF12 ratio | GCST90314894 | 0.16 |
| 7151 | Right-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302834 | 0.16 |
| 7152 | Cholesteryl ester_14:0_[M+NH4]1+ levels | GCST90060197 | 0.16 |
| 7153 | Retrobulbar neuritis in diseases classified elsewhere | FING00001265 | 0.16 |
| 7154 | aparc-pial lh area lateralorbitofrontal | GCST90003152 | 0.16 |
| 7155 | Mean corpuscular hemoglobin variance | GCST90565693 | 0.16 |
| 7156 | CXCL5 levels | GCST90468932 | 0.16 |
| 7157 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501068 | 0.16 |
| 7158 | IL1R2/MEGF9 ratio | GCST90315159 | 0.16 |
| 7159 | FAM174A levels | GCST90241914 | 0.16 |
| 7160 | Total lipid levels in medium HDL | GCST90092898 | 0.16 |
| 7161 | Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney disease | GCST90266016 | 0.16 |
| 7162 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182 | ECGA000182 | 0.16 |
| 7163 | Cholesteryl esters in small HDL (UKB data field 23576) | GCST90269673 | 0.16 |
| 7164 | Comparative body size at age 10 | Early life factors | UKBB00000142 | 0.16 |
| 7165 | GCG levels | GCST90469316 | 0.16 |
| 7166 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502147 | 0.16 |
| 7167 | Asthma | GCST006862 | 0.16 |
| 7168 | DTI autoptx L3 ifo l tract | GCST90385205 | 0.16 |
| 7169 | 1-(1-enyl-palmitoyl)-GPC (p-16:0) levels | GCST90199899 | 0.16 |
| 7170 | CLEC1B/SNAP29 ratio | GCST90314103 | 0.16 |
| 7171 | DAG1/GP6 ratio | GCST90314375 | 0.16 |
| 7172 | SERPINE1/SPARC ratio | GCST90315834 | 0.16 |
| 7173 | ACTA2 levels | GCST90468208 | 0.16 |
| 7174 | LGALS8 levels | GCST90469764 | 0.16 |
| 7175 | CD84/DAG1 ratio | GCST90313910 | 0.16 |
| 7176 | IDP T1 FAST ROIs V cerebellum crus II | GCST90002573 | 0.16 |
| 7177 | Sum neutrophil eosinophil counts | GCST004613 | 0.16 |
| 7178 | rfMRI amplitudes (ICA100 node 28) | GCST90004616 | 0.16 |
| 7179 | Phenylacetate levels | GCST90199630 | 0.16 |
| 7180 | Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211) | GCST90043552 | 0.16 |
| 7181 | PTPN1 levels | GCST90470376 | 0.16 |
| 7182 | Seborrhoeic keratosis | FING00001283 | 0.16 |
| 7183 | EREG levels | GCST90469145 | 0.16 |
| 7184 | GOT1 levels | GCST90469379 | 0.16 |
| 7185 | CEACAM19 levels | GCST90468691 | 0.16 |
| 7186 | TDRKH/TST ratio | GCST90315913 | 0.16 |
| 7187 | BCAN/CD200 ratio | GCST90313477 | 0.16 |
| 7188 | CCL5/CXCL3 ratio | GCST90313700 | 0.16 |
| 7189 | IL18RAP levels | GCST90469566 | 0.16 |
| 7190 | Myocardial fractal dimension (slice 5) | GCST90000291 | 0.16 |
| 7191 | CD83/LAMP3 ratio | GCST90313906 | 0.16 |
| 7192 | aparc-a2009s lh area G-precentral | GCST90003325 | 0.16 |
| 7193 | aparc-DKTatlas rh volume pericalcarine | GCST90002912 | 0.16 |
| 7194 | Bell pepper liking | GCST90094703 | 0.16 |
| 7195 | RETN levels | GCST90470457 | 0.16 |
| 7196 | PAFAH1B3 levels | GCST90470145 | 0.16 |
| 7197 | Left ventricular end diastolic volume (indexed to body surface area) | GCST90435258 | 0.16 |
| 7198 | Chronic airway obstruction | respiratory | UKBB00000135 | 0.16 |
| 7199 | DKK1/PPCDC ratio | GCST90314477 | 0.16 |
| 7200 | CD200/CNTNAP2 ratio | GCST90313747 | 0.16 |
| 7201 | Anti-human herpes virus 6 IE1A IgG seropositivity | GCST90006903 | 0.16 |
| 7202 | Phosphatidylcholine (14:0_22:6) levels | GCST90024234 | 0.16 |
| 7203 | HEXIM1/NUB1 ratio | GCST90315049 | 0.16 |
| 7204 | MMP7 levels | GCST90469921 | 0.16 |
| 7205 | Concentration of HDL particles | GCST90092826 | 0.16 |
| 7206 | PCDH12 levels | GCST90470168 | 0.16 |
| 7207 | CTSE levels | GCST90468911 | 0.16 |
| 7208 | SERPINA5 levels | GCST90470585 | 0.16 |
| 7209 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86 | ECGU000086 | 0.16 |
| 7210 | DTI autoptx L3 ilf r tract | GCST90385208 | 0.16 |
| 7211 | HBEGF/YES1 ratio | GCST90315039 | 0.16 |
| 7212 | MTSS2 levels | GCST90469961 | 0.16 |
| 7213 | ADIPOQ levels | GCST90293086 | 0.16 |
| 7214 | PSTPIP2 levels | GCST90470366 | 0.16 |
| 7215 | Triglycerides to Total Lipids in IDL percentage | GCST90497682 | 0.16 |
| 7216 | Triglycerides in large LDL | GCST90498083 | 0.16 |
| 7217 | T1 FreeSurfer aseg Right-Pallidum | GCST90384164 | 0.16 |
| 7218 | Saturated fatty acids levels | GCST90499953 | 0.16 |
| 7219 | Cerebrospinal fluid sulfate* levels | GCST90318056 | 0.16 |
| 7220 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499637 | 0.16 |
| 7221 | IDP T1 FAST ROIs L cerebellum crus I | GCST90002569 | 0.16 |
| 7222 | Hip circumference (UKB data field 49) | GCST90468170 | 0.16 |
| 7223 | TIMP4 levels | GCST90470872 | 0.16 |
| 7224 | Plasma lysine levels in chronic kidney disease | GCST90265459 | 0.16 |
| 7225 | Hearing difficulty with background noise | GCST90245775 | 0.16 |
| 7226 | Honey liking | GCST90094782 | 0.16 |
| 7227 | TEK levels | GCST90012013 | 0.16 |
| 7228 | Free cholesterol levels in VLDL | GCST90092998 | 0.16 |
| 7229 | DKK1/VASH1 ratio | GCST90314482 | 0.16 |
| 7230 | DDC levels | GCST90468967 | 0.16 |
| 7231 | CASP3/PDGFA ratio | GCST90313637 | 0.16 |
| 7232 | T1 FreeSurfer a2009s rh G cuneus volume | GCST90385048 | 0.16 |
| 7233 | Cerebrospinal fluid 5-methylthioadenosine (MTA) levels | GCST90318216 | 0.16 |
| 7234 | CPB1 levels | GCST90240597 | 0.16 |
| 7235 | TRAF3 levels | GCST90470957 | 0.16 |
| 7236 | Lymphangioleiomyomatosis (sporadic) | GCST008311 | 0.16 |
| 7237 | Total lipids in medium VLDL | GCST90499004 | 0.15 |
| 7238 | Atrial fibrillation and flutter | Other forms of heart disease | UKBB00000056 | 0.15 |
| 7239 | RGMA levels | GCST90470463 | 0.15 |
| 7240 | Concentration of medium VLDL particles | GCST90499016 | 0.15 |
| 7241 | Sphingomyelins levels | GCST90499972 | 0.15 |
| 7242 | Volume of right central nucleus | GCST90475027 | 0.15 |
| 7243 | Regional enteritis (PheCode 555.1) | GCST90476066 | 0.15 |
| 7244 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497539 | 0.15 |
| 7245 | Malignant neoplasm of female breast (PheCode 174.11) | GCST90041833 | 0.15 |
| 7246 | Severe hearing loss or partial deafness in one or both ears | GCST90475385 | 0.15 |
| 7247 | Duration of vigorous activity | Physical activity | UKBB00000199 | 0.15 |
| 7248 | MERTK levels | GCST90469890 | 0.15 |
| 7249 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452 | ECGU000452 | 0.15 |
| 7250 | CD302/CD99 ratio | GCST90313805 | 0.15 |
| 7251 | PAG1 levels | GCST90470147 | 0.15 |
| 7252 | IDP dMRI TBSS FA Sagittal stratum R | GCST90003907 | 0.15 |
| 7253 | Sum basophil neutrophil counts | GCST004620 | 0.15 |
| 7254 | Cholesterol in IDL | GCST90497501 | 0.15 |
| 7255 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58 | ECGA000058 | 0.15 |
| 7256 | HMBS/PKLR ratio | GCST90315063 | 0.15 |
| 7257 | aparc-a2009s lh volume G-pariet-inf-Supramar | GCST90002950 | 0.15 |
| 7258 | ENO2/MANF ratio | GCST90314662 | 0.15 |
| 7259 | Number of attempts | Prospective memory | UKBB00000531 | 0.15 |
| 7260 | RAB11FIP3 levels | GCST90470404 | 0.15 |
| 7261 | Sjögren's syndrome | GCST90018700 | 0.15 |
| 7262 | DKK1/SERPINE1 ratio | GCST90314480 | 0.15 |
| 7263 | Colorectal cancer (PheCode 153) | GCST90475566 | 0.15 |
| 7264 | Free Cholesterol in HDL | GCST90497379 | 0.15 |
| 7265 | IDP dMRI TBSS L3 Inferior cerebellar peduncle L | GCST90004182 | 0.15 |
| 7266 | IDP dMRI TBSS ICVF Posterior corona radiata L | GCST90004354 | 0.15 |
| 7267 | Alpha-hydroxyisovalerate levels | GCST90199736 | 0.15 |
| 7268 | LAT/SERPINE1 ratio | GCST90315287 | 0.15 |
| 7269 | Cholesterol to Total Lipids in IDL percentage | GCST90497511 | 0.15 |
| 7270 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 20) | GCST90320839 | 0.15 |
| 7271 | MPIG6B/SUSD1 ratio | GCST90315487 | 0.15 |
| 7272 | Nonspecific chest pain (PheCode 418) | GCST90475947 | 0.15 |
| 7273 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408 | ECGU000408 | 0.15 |
| 7274 | Height decline (log-difference score) | GCST90565853 | 0.15 |
| 7275 | VLDL cholesterol levels (UKB data field 23403) | GCST90269500 | 0.15 |
| 7276 | ANGPT1/SERPINE1 ratio | GCST90313269 | 0.15 |
| 7277 | Fracture of upper limb (PheCode 803) | GCST90476279 | 0.15 |
| 7278 | CD22/FCRL1 ratio | GCST90313757 | 0.15 |
| 7279 | 2s,3R-dihydroxybutyrate levels | GCST90199882 | 0.15 |
| 7280 | Free cholesterol to total lipids ratio in medium LDL | GCST90092909 | 0.15 |
| 7281 | Triglycerides to Total Lipids in Very Large HDL percentage | GCST90500506 | 0.15 |
| 7282 | PRCP/SELE ratio | GCST90315726 | 0.15 |
| 7283 | Total free cholesterol levels | GCST90500072 | 0.15 |
| 7284 | INSL5 levels | GCST90469622 | 0.15 |
| 7285 | INSL4 levels | GCST90469621 | 0.15 |
| 7286 | Granulocyte count | GCST004614 | 0.15 |
| 7287 | PPP1R2/TBL1X ratio | GCST90315720 | 0.15 |
| 7288 | CALB2 levels | GCST90468527 | 0.15 |
| 7289 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T142 | ECGA000142 | 0.15 |
| 7290 | Omega-3 fatty acid levels | GCST90502424 | 0.15 |
| 7291 | Platelet count | GCST90278640 | 0.15 |
| 7292 | Free cholesterol to total lipids ratio in IDL | GCST90092836 | 0.15 |
| 7293 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T147 | ECGU000147 | 0.15 |
| 7294 | High light scatter reticulocyte count | GCST004611 | 0.15 |
| 7295 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500918 | 0.15 |
| 7296 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497929 | 0.15 |
| 7297 | HGF/PLAUR ratio | GCST90315059 | 0.15 |
| 7298 | Pregnancy with abortive outcome | FING00001205 | 0.15 |
| 7299 | ACAA1 levels | GCST90468193 | 0.15 |
| 7300 | CCN2/VEGFC ratio | GCST90313719 | 0.15 |
| 7301 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502373 | 0.15 |
| 7302 | T1 CAT volume R RightPutamen | GCST90384101 | 0.15 |
| 7303 | B4GALT1/IFNGR1 ratio | GCST90313430 | 0.15 |
| 7304 | CEBPB/PXN ratio | GCST90314008 | 0.15 |
| 7305 | RNF43 levels | GCST90422482 | 0.15 |
| 7306 | DTI TBSS MD Splenium of corpus callosum | GCST90384576 | 0.15 |
| 7307 | IQGAP2/STX4 ratio | GCST90315190 | 0.15 |
| 7308 | Prostate cancer | GCST90274716 | 0.15 |
| 7309 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499831 | 0.15 |
| 7310 | IL27 levels | GCST90012017 | 0.15 |
| 7311 | UPB1 levels | GCST90471013 | 0.15 |
| 7312 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171 | ECGU000171 | 0.15 |
| 7313 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T267 | ECGA000267 | 0.15 |
| 7314 | aparc-a2009s rh volume S-oc-temp-med+Lingual | GCST90003059 | 0.15 |
| 7315 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498653 | 0.15 |
| 7316 | Cerebral amyloid angiopathy | FING00000262 | 0.15 |
| 7317 | F11R/SORT1 ratio | GCST90314726 | 0.15 |
| 7318 | DTI TBSS MD Posterior thalamic radiation L | GCST90384601 | 0.15 |
| 7319 | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | GCST90004343 | 0.15 |
| 7320 | LGALS9 levels | GCST90469765 | 0.15 |
| 7321 | NUDT5/RWDD1 ratio | GCST90315580 | 0.15 |
| 7322 | SFTPA2/SFTPD ratio | GCST90315839 | 0.15 |
| 7323 | CDSN/KLK8 ratio | GCST90313996 | 0.15 |
| 7324 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T53 | ECGU000053 | 0.15 |
| 7325 | AFM levels | GCST90468249 | 0.15 |
| 7326 | Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditions | UKBB00000513 | 0.15 |
| 7327 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497576 | 0.15 |
| 7328 | TNFRSF13B/TNFRSF9 ratio | GCST90315932 | 0.15 |
| 7329 | RNF146 levels | GCST90421479 | 0.15 |
| 7330 | Free cholesterol in medium VLDL (UKB data field 23507) | GCST90269604 | 0.15 |
| 7331 | PAPPA levels | GCST90470157 | 0.15 |
| 7332 | THOP1 levels | GCST90470856 | 0.15 |
| 7333 | CAG-273 sp003507395 abundance in stool | GCST90032269 | 0.15 |
| 7334 | Triglycerides in small LDL | GCST90499712 | 0.15 |
| 7335 | PLXNB3 levels | GCST90470267 | 0.15 |
| 7336 | Thyroiditis, unspecified | FING00001359 | 0.15 |
| 7337 | ENO2/RWDD1 ratio | GCST90314667 | 0.15 |
| 7338 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162 | ECGU000162 | 0.15 |
| 7339 | Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivity | GCST90302735 | 0.15 |
| 7340 | VEGFD levels | GCST90012069 | 0.14 |
| 7341 | Phospholipids to Total Lipids in Small VLDL percentage | GCST90499902 | 0.14 |
| 7342 | Irregular menstrual cycle/bleeding | genitourinary | UKBB00000379 | 0.14 |
| 7343 | IDP T1 FAST ROIs R cerebellum VI | GCST90002568 | 0.14 |
| 7344 | ITIH3/VCAM1 ratio | GCST90315236 | 0.14 |
| 7345 | Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605) | GCST90269702 | 0.14 |
| 7346 | Total lipids in small LDL | GCST90499656 | 0.14 |
| 7347 | Total cholesterol levels | GCST90500022 | 0.14 |
| 7348 | PDGFB/PRKAR1A ratio | GCST90315624 | 0.14 |
| 7349 | Beef consumption (UKB data field 1369) | GCST90132997 | 0.14 |
| 7350 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T141 | ECGA000141 | 0.14 |
| 7351 | CLIP2/LAT2 ratio | GCST90314128 | 0.14 |
| 7352 | PSRC1 levels | GCST90470365 | 0.14 |
| 7353 | Phospholipids in medium HDL | GCST90498641 | 0.14 |
| 7354 | Total lipids in medium HDL | GCST90498597 | 0.14 |
| 7355 | S100A4/SNAP29 ratio | GCST90315801 | 0.14 |
| 7356 | Chronic bronchitis | GCST90018604 | 0.14 |
| 7357 | Venous thromboembolism | FING00001427 | 0.14 |
| 7358 | LDL cholesterol levels | GCST90498353 | 0.14 |
| 7359 | Ceramide_40:1_[M-H]1- levels | GCST90060198 | 0.14 |
| 7360 | PTPRF levels | GCST90470381 | 0.14 |
| 7361 | Radiculopathy | FING00001238 | 0.14 |
| 7362 | Infections of the skin and subcutaneous tissue | FING00000670 | 0.14 |
| 7363 | Triglycerides to total lipids in medium LDL percentage (UKB data field 23623) | GCST90269720 | 0.14 |
| 7364 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371 | ECGA000371 | 0.14 |
| 7365 | Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels | GCST90200118 | 0.14 |
| 7366 | ADH4/KYNU ratio | GCST90313193 | 0.14 |
| 7367 | CKAP4/PGF ratio | GCST90314075 | 0.14 |
| 7368 | SPINK4 levels | GCST90470723 | 0.14 |
| 7369 | ITGB1/MCAM ratio | GCST90315226 | 0.14 |
| 7370 | GM3 ganglioside (d18:1/24:0) levels | GCST90025340 | 0.14 |
| 7371 | Phospholipids in very small VLDL (UKB data field 23518) | GCST90269615 | 0.14 |
| 7372 | Concentration of large LDL particles | GCST90498029 | 0.14 |
| 7373 | Takes medication for Diabetes/sugar? | GCST90475268 | 0.14 |
| 7374 | ARSA/CD164 ratio | GCST90313351 | 0.14 |
| 7375 | Lysophosphatidylcholine (24:0) [sn1] levels | GCST90025425 | 0.14 |
| 7376 | Spondylosis and allied disorders (PheCode 721) | GCST90476235 | 0.14 |
| 7377 | PDLIM7 levels | GCST90470198 | 0.14 |
| 7378 | Worrier / anxious feelings | Mental health | UKBB00000921 | 0.14 |
| 7379 | VLDL cholesterol levels | GCST90500196 | 0.14 |
| 7380 | BCAN levels | GCST90468426 | 0.14 |
| 7381 | Phospholipid levels in VLDL | GCST90093001 | 0.14 |
| 7382 | APOA1 levels | GCST90497119 | 0.14 |
| 7383 | ADA levels | GCST90468231 | 0.14 |
| 7384 | Triglycerides in very small VLDL (UKB data field 23522) | GCST90269619 | 0.14 |
| 7385 | IDP dMRI TBSS ICVF Superior corona radiata L | GCST90004352 | 0.14 |
| 7386 | LZTFL1 levels | GCST90469834 | 0.14 |
| 7387 | Triglycerides to total lipids in small LDL percentage (UKB data field 23628) | GCST90269725 | 0.14 |
| 7388 | Triglycerides in IDL | GCST90497661 | 0.14 |
| 7389 | Docosahexaenoic acid to total fatty acids percentage | GCST90502268 | 0.14 |
| 7390 | LYVE1 levels | GCST90469832 | 0.14 |
| 7391 | Concentration of small LDL particles | GCST90499660 | 0.14 |
| 7392 | Phospholipids to total lipids in IDL percentage (UKB data field 23609) | GCST90269706 | 0.14 |
| 7393 | FLT1/TGFB1 ratio | GCST90314857 | 0.14 |
| 7394 | 5alpha-pregnan-3beta,20alpha-diol monosulfate (2) levels | GCST90199854 | 0.14 |
| 7395 | Saturated fatty acids levels | GCST90502670 | 0.14 |
| 7396 | Cholesterol to total lipids in medium LDL percentage (UKB data field 23620) | GCST90269717 | 0.14 |
| 7397 | Cereal type - Muesli | Diet | UKBB00000123 | 0.14 |
| 7398 | Vanillactate levels | GCST90199978 | 0.14 |
| 7399 | PLIN3/TYMP ratio | GCST90315678 | 0.14 |
| 7400 | LDL (weighted GWA) | GCST90267273 | 0.14 |
| 7401 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T197 | ECGU000197 | 0.14 |
| 7402 | AMOT levels | GCST90468295 | 0.14 |
| 7403 | Eosinophil count variance | GCST90565689 | 0.14 |
| 7404 | CD244/CD84 ratio | GCST90313762 | 0.14 |
| 7405 | Total lipids in large LDL | GCST90498021 | 0.14 |
| 7406 | Childhood body mass index | GCST90002409 | 0.14 |
| 7407 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T66 | ECGA000066 | 0.14 |
| 7408 | Alcohol usually taken with meals | Alcohol | UKBB00000025 | 0.14 |
| 7409 | CBLIF levels | GCST90468552 | 0.14 |
| 7410 | BSG/CKAP4 ratio | GCST90313531 | 0.14 |
| 7411 | RHOC levels | GCST90470467 | 0.14 |
| 7412 | Phospholipid levels in small HDL | GCST90092952 | 0.14 |
| 7413 | Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302658 | 0.14 |
| 7414 | severe traumatic brain injury, does not include concussion | FING00001300 | 0.14 |
| 7415 | Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications | GCST90093113 | 0.14 |
| 7416 | MESD/WWP2 ratio | GCST90315426 | 0.14 |
| 7417 | wg rh intensity-contrast postcentral | GCST90003848 | 0.14 |
| 7418 | COMT levels | GCST90468828 | 0.14 |
| 7419 | DTI autoptx FA slf r tract | GCST90385134 | 0.14 |
| 7420 | Omega-3 fatty acids to total fatty acids percentage | GCST90499155 | 0.14 |
| 7421 | NECTIN2 levels | GCST90470020 | 0.14 |
| 7422 | Right-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302844 | 0.14 |
| 7423 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T92 | ECGU000092 | 0.14 |
| 7424 | NBL1/TGFBR2 ratio | GCST90315515 | 0.14 |
| 7425 | F-carbohydrate liking (derived food-liking factor) | GCST90094725 | 0.14 |
| 7426 | Spread type: Butter vs never use spread (UKB data field 1428) | GCST90132952 | 0.14 |
| 7427 | S100A11 levels | GCST90470512 | 0.14 |
| 7428 | ENPP5 levels | GCST90469116 | 0.14 |
| 7429 | Concentration of small HDL particles (UKB data field 23572) | GCST90269669 | 0.14 |
| 7430 | Cholesterol in Large LDL | GCST90497923 | 0.14 |
| 7431 | HLA-DQA2 levels | GCST90427049 | 0.14 |
| 7432 | ANG levels | GCST90468307 | 0.14 |
| 7433 | HBEGF levels | GCST90241392 | 0.14 |
| 7434 | Pulmonary heart disease (PheCode 415) | GCST90475942 | 0.14 |
| 7435 | Volume of right medial nucleus | GCST90475045 | 0.14 |
| 7436 | CCL8 levels | GCST90468586 | 0.14 |
| 7437 | Triglyceride levels in medium VLDL | GCST90092926 | 0.14 |
| 7438 | Cerebral aneurysm | GCST90018595 | 0.14 |
| 7439 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91 | ECGU000091 | 0.14 |
| 7440 | Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302835 | 0.14 |
| 7441 | Ratio of monounsaturated fatty acids to total fatty acids | GCST90092929 | 0.14 |
| 7442 | monocyte (absolute count, mean, inv-norm transformed) | GCST90475502 | 0.14 |
| 7443 | Illnesses of father - High blood pressure | Family history | UKBB00000343 | 0.14 |
| 7444 | NECTIN2/TNFRSF14 ratio | GCST90315531 | 0.14 |
| 7445 | CD27/CD79B ratio | GCST90313770 | 0.14 |
| 7446 | 5-hydroxyindole sulfate levels | GCST90200050 | 0.14 |
| 7447 | Triacylglycerol_52:6_[M+NH4]1+ levels | GCST90060504 | 0.14 |
| 7448 | aseg rh volume Cerebellum-Cortex | GCST90002636 | 0.14 |
| 7449 | KLK6 levels | GCST90012008 | 0.14 |
| 7450 | Peripheral vascular disease | GCST90475219 | 0.14 |
| 7451 | Volume of left central nucleus | GCST90474883 | 0.14 |
| 7452 | Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) | GCST90269690 | 0.14 |
| 7453 | FCGR2A/FCGR2B ratio | GCST90314793 | 0.14 |
| 7454 | Omega-3 fatty acids to total fatty acids percentage | GCST90502463 | 0.14 |
| 7455 | Plasma iron levels | GCST90100546 | 0.14 |
| 7456 | CLEC1A/CLEC7A ratio | GCST90314083 | 0.14 |
| 7457 | IDP dMRI TBSS L1 Anterior corona radiata R | GCST90004097 | 0.14 |
| 7458 | SPARC/TJAP1 ratio | GCST90315873 | 0.14 |
| 7459 | Cholesteryl esters to total lipids ratio in very large VLDL | GCST90093019 | 0.14 |
| 7460 | aparc-a2009s rh volume S-intrapariet+P-trans | GCST90003054 | 0.14 |
| 7461 | Atrial fibrillation and flutter | circulatory system | UKBB00000055 | 0.13 |
| 7462 | T1 FreeSurfer DKT lh lateraloccipital area | GCST90384202 | 0.13 |
| 7463 | RARRES2 levels | GCST90470428 | 0.13 |
| 7464 | ITGA5/SELE ratio | GCST90315205 | 0.13 |
| 7465 | IDP dMRI TBSS ICVF Superior cerebellar peduncle R | GCST90004339 | 0.13 |
| 7466 | Triglyceride levels in small VLDL | GCST90132667 | 0.13 |
| 7467 | DOK2/FADD ratio | GCST90314530 | 0.13 |
| 7468 | Docosahexaenoic acid levels | GCST90501986 | 0.13 |
| 7469 | PLA2G4A/SDC4 ratio | GCST90315668 | 0.13 |
| 7470 | DTI TBSS FA Uncinate fasciculus L | GCST90384425 | 0.13 |
| 7471 | Lateral epicondylitis | FING00000715 | 0.13 |
| 7472 | LAT2/MANF ratio | GCST90315277 | 0.13 |
| 7473 | MAVS/RNF41 ratio | GCST90315395 | 0.13 |
| 7474 | PDGFB/UXS1 ratio | GCST90315634 | 0.13 |
| 7475 | EIF4G1/FOXO1 ratio | GCST90314634 | 0.13 |
| 7476 | Omega-3 fatty acids to total fatty acids percentage | GCST90502466 | 0.13 |
| 7477 | ADH4/SCLY ratio | GCST90313195 | 0.13 |
| 7478 | Thyroxine levels | GCST90200293 | 0.13 |
| 7479 | Free cholesterol levels in medium VLDL | GCST90092920 | 0.13 |
| 7480 | COL2A1 levels | GCST90468816 | 0.13 |
| 7481 | monocyte (absolute count, maximum, inv-norm transformed) | GCST90475499 | 0.13 |
| 7482 | LSP1 levels | GCST90469811 | 0.13 |
| 7483 | CCN2/ENO2 ratio | GCST90313712 | 0.13 |
| 7484 | PDP1 levels | GCST90424296 | 0.13 |
| 7485 | Total fatty acid levels | GCST90500061 | 0.13 |
| 7486 | Hearing difficulty and hearing difficulty with background noise | GCST90245776 | 0.13 |
| 7487 | Average diameter for LDL particles (UKB data field 23432) | GCST90269529 | 0.13 |
| 7488 | LDLR/PCSK9 ratio | GCST90315311 | 0.13 |
| 7489 | ANGPT1/DKK1 ratio | GCST90313263 | 0.13 |
| 7490 | Episcleritis | FING00000513 | 0.13 |
| 7491 | Operative procedures - Direct current cardioversion | Summary Operations | UKBB00000576 | 0.13 |
| 7492 | Other and unspecified iron deficiency | FING00000940 | 0.13 |
| 7493 | Androsterone sulfate levels | GCST90200674 | 0.13 |
| 7494 | CLEC14A/PTPRS ratio | GCST90314081 | 0.13 |
| 7495 | CCN2 levels | GCST90468588 | 0.13 |
| 7496 | GATD3 levels | GCST90469309 | 0.13 |
| 7497 | DKK1/LGALS8 ratio | GCST90314472 | 0.13 |
| 7498 | CSNK2A1 or CSNK2B levels | GCST90088963 | 0.13 |
| 7499 | Recent worrying too much about different things | Anxiety | UKBB00000746 | 0.13 |
| 7500 | CLC/RNASE3 ratio | GCST90314077 | 0.13 |
| 7501 | aparc-Desikan lh area precuneus | GCST90003097 | 0.13 |
| 7502 | Cholesteryl Esters to Total Lipids in Small LDL percentage | GCST90499602 | 0.13 |
| 7503 | Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivity | GCST90302759 | 0.13 |
| 7504 | Volume of right medial nucleus | GCST90475042 | 0.13 |
| 7505 | Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611) | GCST90269708 | 0.13 |
| 7506 | Abnormal findings examination of lungs (PheCode 514) | GCST90476043 | 0.13 |
| 7507 | Epiandrosterone sulfate levels | GCST90199752 | 0.13 |
| 7508 | CCN2/SERPINB1 ratio | GCST90313715 | 0.13 |
| 7509 | Worry | GCST006478 | 0.13 |
| 7510 | CRKL/MGLL ratio | GCST90314270 | 0.13 |
| 7511 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T437 | ECGU000437 | 0.13 |
| 7512 | XCL1 levels | GCST90471081 | 0.13 |
| 7513 | Concentration of IDL particles | GCST90497614 | 0.13 |
| 7514 | A4GALT levels | GCST90427457 | 0.13 |
| 7515 | aparc-Desikan rh area fusiform | GCST90003113 | 0.13 |
| 7516 | PBXIP1 levels | GCST90470164 | 0.13 |
| 7517 | FABP1 levels | GCST90469173 | 0.13 |
| 7518 | DTI autoptx MD cgc r tract | GCST90385225 | 0.13 |
| 7519 | AHSP/CA2 ratio | GCST90313215 | 0.13 |
| 7520 | aparc-Desikan rh volume lingual | GCST90002813 | 0.13 |
| 7521 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T138 | ECGA000138 | 0.13 |
| 7522 | Alcohol drinker status - Current | Alcohol | UKBB00000021 | 0.13 |
| 7523 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T244 | ECGA000244 | 0.13 |
| 7524 | METAP1D/VASH1 ratio | GCST90315429 | 0.13 |
| 7525 | SCPEP1 levels | GCST90470553 | 0.13 |
| 7526 | Cholesterol levels in small VLDL | GCST90092968 | 0.13 |
| 7527 | MARCO/SIGLEC1 ratio | GCST90315387 | 0.13 |
| 7528 | Docosahexaenoic acid to total fatty acids percentage | GCST90501999 | 0.13 |
| 7529 | 3-hydroxydecanoate metabolite level | GCST90615472 | 0.13 |
| 7530 | Prescriptions - ACE inhibitor|anti-hypertensive | UKBB00000657 | 0.13 |
| 7531 | SCRN1 levels | GCST90470556 | 0.13 |
| 7532 | GP6/SELP ratio | GCST90314970 | 0.13 |
| 7533 | DKK1/PTPN6 ratio | GCST90314478 | 0.13 |
| 7534 | COLEC12/NBL1 ratio | GCST90314183 | 0.13 |
| 7535 | aparc-DKTatlas rh volume lingual | GCST90002904 | 0.13 |
| 7536 | HDL cholesterol levels | GCST90497340 | 0.13 |
| 7537 | HDAC8 levels | GCST90469438 | 0.13 |
| 7538 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | GCST90269681 | 0.13 |
| 7539 | Left-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302772 | 0.13 |
| 7540 | BTC levels | GCST90468476 | 0.13 |
| 7541 | Right-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302848 | 0.13 |
| 7542 | High cholesterol | GCST90475203 | 0.13 |
| 7543 | DTI TBSS L3 Posterior thalamic radiation L | GCST90384553 | 0.13 |
| 7544 | Omega-3 fatty acid levels | GCST90502425 | 0.13 |
| 7545 | PBLD levels | GCST90470163 | 0.13 |
| 7546 | MPO levels | GCST90012031 | 0.13 |
| 7547 | Cholesteryl ester levels in VLDL | GCST90092997 | 0.13 |
| 7548 | Congenital malformations of genital organs | FING00000333 | 0.13 |
| 7549 | Total cholines levels | GCST90497185 | 0.13 |
| 7550 | Left ventricular outflow tract obstruction (LVOTO), broad definition | FING00000717 | 0.13 |
| 7551 | VLDL cholesterol levels | GCST90092996 | 0.13 |
| 7552 | Citrate levels | GCST90497200 | 0.13 |
| 7553 | CALCOCO1/TBC1D5 ratio | GCST90313610 | 0.13 |
| 7554 | Brainstem global volume Whole-brainstem | GCST90002768 | 0.13 |
| 7555 | Concentration of small LDL particles | GCST90499669 | 0.13 |
| 7556 | rfMRI connectivity (ICA100 edge 912) | GCST90005765 | 0.13 |
| 7557 | SERPINH1 levels | GCST90470601 | 0.13 |
| 7558 | Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646) | GCST90269743 | 0.13 |
| 7559 | Cholesteryl Esters in IDL | GCST90497525 | 0.13 |
| 7560 | X-13671 levels | GCST90243829 | 0.13 |
| 7561 | Cervicalgia (PheCode 761) | GCST90476267 | 0.13 |
| 7562 | Concentration of LDL particles | GCST90498418 | 0.13 |
| 7563 | CD2AP levels | GCST90468617 | 0.13 |
| 7564 | MUC2 levels | GCST90469965 | 0.13 |
| 7565 | White blood cell count | GCST90278647 | 0.13 |
| 7566 | Serum urea levels | GCST90025991 | 0.13 |
| 7567 | Collagenous colitis | GCST90204145 | 0.13 |
| 7568 | X-21353 metabolite level | GCST90616708 | 0.13 |
| 7569 | Left-hemisphere visual network to pallidum white-matter structural connectivity | GCST90302665 | 0.13 |
| 7570 | Coffee type - Instant coffee | Diet | UKBB00000141 | 0.13 |
| 7571 | LAYN levels | GCST90469742 | 0.13 |
| 7572 | Uterine fibroids | GCST90018714 | 0.13 |
| 7573 | IDP T1 FAST ROIs R mid front gyrus | GCST90002458 | 0.13 |
| 7574 | DTI TBSS MD Superior corona radiata L | GCST90384597 | 0.13 |
| 7575 | Otitis media and Eustachian tube disorders (PheCode 381) | GCST90475902 | 0.13 |
| 7576 | CTSF levels | GCST90468912 | 0.13 |
| 7577 | Other ulcerative colitis | FING00001117 | 0.13 |
| 7578 | DNAJC21 levels | GCST90469016 | 0.13 |
| 7579 | CKMB levels | GCST90475221 | 0.13 |
| 7580 | Concentration of very small VLDL particles | GCST90093035 | 0.13 |
| 7581 | CASP10/ING1 ratio | GCST90313625 | 0.13 |
| 7582 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499335 | 0.13 |
| 7583 | Total lipid levels in small HDL | GCST90092950 | 0.13 |
| 7584 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394 | ECGU000394 | 0.13 |
| 7585 | Frequency of stair climbing in last 4 weeks | Physical activity | UKBB00000266 | 0.13 |
| 7586 | F-salty food liking (derived food-liking factor) | GCST90094827 | 0.13 |
| 7587 | Free cholesterol in small VLDL | GCST90499808 | 0.13 |
| 7588 | EFNA4/TNFRSF9 ratio | GCST90314606 | 0.13 |
| 7589 | Linoleic acid to total fatty acids percentage | GCST90502320 | 0.13 |
| 7590 | BCAN/KLK6 ratio | GCST90313479 | 0.13 |
| 7591 | Cholesterol to total lipids ratio in very small VLDL | GCST90093029 | 0.13 |
| 7592 | ACVRL1 levels | GCST90468211 | 0.13 |
| 7593 | CASP3/SERPINE1 ratio | GCST90313643 | 0.13 |
| 7594 | Ptosis of eyelid | FING00001227 | 0.13 |
| 7595 | Disorders of lipoprotein metabolism and other lipidaemias | FING00000442 | 0.13 |
| 7596 | Docosahexaenoic acid levels | GCST90502259 | 0.13 |
| 7597 | Omega-3 fatty acids to total fatty acids percentage | GCST90502450 | 0.13 |
| 7598 | Other reaction to severe stress, and adjustment disorders | FING00001092 | 0.13 |
| 7599 | CXCL14 levels | GCST90468927 | 0.13 |
| 7600 | Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivity | GCST90302720 | 0.12 |
| 7601 | FCN1 levels | GCST90469203 | 0.12 |
| 7602 | KLK11/KLK8 ratio | GCST90315254 | 0.12 |
| 7603 | GPC5 levels | GCST90469387 | 0.12 |
| 7604 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T137 | ECGA000137 | 0.12 |
| 7605 | Benign neoplasm of colon (PheCode 208) | GCST90475617 | 0.12 |
| 7606 | FADD/NCK2 ratio | GCST90314770 | 0.12 |
| 7607 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170 | ECGA000170 | 0.12 |
| 7608 | ANGPTL3 levels | GCST90468304 | 0.12 |
| 7609 | IDP dMRI TBSS OD Anterior limb of internal capsule L | GCST90004419 | 0.12 |
| 7610 | Diacylglycerol_36:1_[M+H-H2O]1+ levels | GCST90060193 | 0.12 |
| 7611 | Brugada syndrome | GCST90295916 | 0.12 |
| 7612 | Extrapyramidal and movement disorders | FING00000527 | 0.12 |
| 7613 | MANF/SDC4 ratio | GCST90315367 | 0.12 |
| 7614 | DLL1/NECTIN4 ratio | GCST90314497 | 0.12 |
| 7615 | Physical activity (Total log acceleration 2am-4am) | GCST90061410 | 0.12 |
| 7616 | Phospholipids in small VLDL | GCST90499881 | 0.12 |
| 7617 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269 | ECGU000269 | 0.12 |
| 7618 | LECT2 levels | GCST90469751 | 0.12 |
| 7619 | Ingrowing nail (PheCode 703.1) | GCST90476208 | 0.12 |
| 7620 | LCAT levels | GCST90469745 | 0.12 |
| 7621 | CXCL11/CXCL13 ratio | GCST90314333 | 0.12 |
| 7622 | Neutrophill count | Blood count | UKBB00000497 | 0.12 |
| 7623 | TPI1 levels | GCST90088659 | 0.12 |
| 7624 | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | GCST90004344 | 0.12 |
| 7625 | Keloid | GCST90018654 | 0.12 |
| 7626 | Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608) | GCST90269705 | 0.12 |
| 7627 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475 | ECGA000475 | 0.12 |
| 7628 | IDP T1 FIRST left pallidum volume | GCST90002442 | 0.12 |
| 7629 | REG4 levels | GCST90470451 | 0.12 |
| 7630 | BAG6 levels | GCST90468418 | 0.12 |
| 7631 | Frailty (General Factor) | GCST90624046 | 0.12 |
| 7632 | ADH4/SORD ratio | GCST90313196 | 0.12 |
| 7633 | CCNE1 levels | GCST90468593 | 0.12 |
| 7634 | total cholesterol (maximum, inv-norm transformed) | GCST90476418 | 0.12 |
| 7635 | Neutrophil count | GCST90002398 | 0.12 |
| 7636 | Added salt consumption | GCST90133001 | 0.12 |
| 7637 | CD99/KITLG ratio | GCST90313924 | 0.12 |
| 7638 | Other bacterial diseases | FING00000968 | 0.12 |
| 7639 | ADA2/VCAM1 ratio | GCST90313167 | 0.12 |
| 7640 | Hepatic cancer | GCST90018638 | 0.12 |
| 7641 | Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivity | GCST90302698 | 0.12 |
| 7642 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256 | ECGU000256 | 0.12 |
| 7643 | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levels | GCST90200083 | 0.12 |
| 7644 | aparc-DKTatlas lh area precuneus | GCST90003257 | 0.12 |
| 7645 | Total Lipids in Medium LDL | GCST90498806 | 0.12 |
| 7646 | Duodenal ulcer | GCST90270928 | 0.12 |
| 7647 | CLIP2/NT5C3A ratio | GCST90314129 | 0.12 |
| 7648 | CCL5 levels | GCST90468584 | 0.12 |
| 7649 | IDP dMRI TBSS MO Pontine crossing tract | GCST90003953 | 0.12 |
| 7650 | IDP SWI T2star right caudate | GCST90003866 | 0.12 |
| 7651 | Concentration of medium LDL particles | GCST90498823 | 0.12 |
| 7652 | Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302651 | 0.12 |
| 7653 | SPARC/ZBTB16 ratio | GCST90315875 | 0.12 |
| 7654 | CRELD1 levels | GCST90468858 | 0.12 |
| 7655 | T1 FreeSurfer DK lh lateraloccipital area | GCST90385598 | 0.12 |
| 7656 | Total fatty acid levels | GCST90502218 | 0.12 |
| 7657 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391 | ECGU000391 | 0.12 |
| 7658 | Left ventricular stroke volume | GCST90268130 | 0.12 |
| 7659 | YBX1 levels | GCST90090799 | 0.12 |
| 7660 | CRADD/SIRT2 ratio | GCST90314243 | 0.12 |
| 7661 | DTI TBSS L1 Cingulum cingulate gyrus L | GCST90384463 | 0.12 |
| 7662 | KRT19 levels | GCST90469717 | 0.12 |
| 7663 | Cholesteryl Esters in VLDL | GCST90500211 | 0.12 |
| 7664 | RELL1 levels | GCST90242625 | 0.12 |
| 7665 | ENPP6 levels | GCST90469117 | 0.12 |
| 7666 | Phospholipids to total lipids ratio in medium HDL | GCST90092901 | 0.12 |
| 7667 | Irritable bowel syndrome | FING00000702 | 0.12 |
| 7668 | Total triglycerides levels | GCST003664 | 0.12 |
| 7669 | Triglycerides to total lipids ratio in IDL | GCST90092842 | 0.12 |
| 7670 | aseg lh intensity Inf-Lat-Vent | GCST90003765 | 0.12 |
| 7671 | KYAT1 levels | GCST90469721 | 0.12 |
| 7672 | Phospholipid levels in medium HDL | GCST90092900 | 0.12 |
| 7673 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273 | ECGA000273 | 0.12 |
| 7674 | FHIT levels | GCST90469238 | 0.12 |
| 7675 | Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731) | GCST90476246 | 0.12 |
| 7676 | aseg lh volume Lateral-Ventricle | GCST90002616 | 0.12 |
| 7677 | aseg global volume Brain-Stem | GCST90002602 | 0.12 |
| 7678 | PRL levels | GCST90470332 | 0.12 |
| 7679 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370 | ECGA000370 | 0.12 |
| 7680 | ANXA1 levels | GCST90468316 | 0.12 |
| 7681 | B4GALT1 levels | GCST90468412 | 0.12 |
| 7682 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497969 | 0.12 |
| 7683 | BAIAP2/MME ratio | GCST90313453 | 0.12 |
| 7684 | DTI autoptx L1 ilf l tract | GCST90385153 | 0.12 |
| 7685 | F-chocolate/coffee liking (derived food-liking factor) | GCST90094735 | 0.12 |
| 7686 | Triglycerides in medium LDL | GCST90498870 | 0.12 |
| 7687 | GABBR2 levels | GCST90241230 | 0.12 |
| 7688 | Uric acid levels | GCST90278646 | 0.12 |
| 7689 | Gout | GCST90399701 | 0.12 |
| 7690 | DTI autoptx L2 slf l tract | GCST90385187 | 0.12 |
| 7691 | Peak expiratory flow | GCST007430 | 0.12 |
| 7692 | T1 CAT volume R CrusI | GCST90384120 | 0.12 |
| 7693 | DHX58 levels | GCST90618238 | 0.12 |
| 7694 | CXCL9 levels | GCST90468935 | 0.12 |
| 7695 | Total phospholipid levels in lipoprotein particles | GCST90500110 | 0.12 |
| 7696 | BAG6/WASF1 ratio | GCST90313452 | 0.12 |
| 7697 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502388 | 0.12 |
| 7698 | IDP dMRI TBSS L3 Posterior limb of internal capsule R | GCST90004189 | 0.12 |
| 7699 | Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary Operations | UKBB00000577 | 0.12 |
| 7700 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446 | ECGU000446 | 0.12 |
| 7701 | Cholesterol to Total Lipids in Small VLDL percentage | GCST90499764 | 0.12 |
| 7702 | Enterocolitis due to Clostridium difficile | FING00000507 | 0.12 |
| 7703 | Liver condition (ex. cirrhosis) | GCST90475270 | 0.12 |
| 7704 | T1 FreeSurfer pial rh pericalcarine area | GCST90385842 | 0.12 |
| 7705 | Peripheral enthesopathies and allied syndromes | musculoskeletal | UKBB00000640 | 0.12 |
| 7706 | TNFRSF11B levels | GCST90470903 | 0.12 |
| 7707 | Capers liking | GCST90094724 | 0.12 |
| 7708 | Phospholipids in medium VLDL (UKB data field 23504) | GCST90269601 | 0.12 |
| 7709 | End-diastolic bi-ventricular shape (principal component 8) | GCST90448487 | 0.12 |
| 7710 | Variation in diet | Diet | UKBB00000892 | 0.12 |
| 7711 | Concentration of small LDL particles (UKB data field 23544) | GCST90269641 | 0.12 |
| 7712 | aparc-pial lh area precuneus | GCST90003165 | 0.12 |
| 7713 | Total Lipids in LDL | GCST90498405 | 0.12 |
| 7714 | F2R/PDGFB ratio | GCST90314733 | 0.12 |
| 7715 | Principal component-derived dietary pattern 17 | GCST90133022 | 0.12 |
| 7716 | Free cholesterol levels in very small VLDL | GCST90093032 | 0.12 |
| 7717 | Types of transport used (excluding work) - Car/motor vehicle | Physical activity | UKBB00000876 | 0.12 |
| 7718 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485 | ECGA000485 | 0.12 |
| 7719 | NPTXR levels | GCST90470080 | 0.12 |
| 7720 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498926 | 0.11 |
| 7721 | Severity of induration at injection site at the injection site after COVID-19 booster vaccination | GCST90454409 | 0.11 |
| 7722 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393 | ECGU000393 | 0.11 |
| 7723 | PADI2 levels | GCST90470142 | 0.11 |
| 7724 | Sebaceous cyst (PheCode 706.2) | GCST90476213 | 0.11 |
| 7725 | Diastolic blood pressure | GCST90278625 | 0.11 |
| 7726 | Thyroid peroxidase antibody levels in pregnancy | GCST90435201 | 0.11 |
| 7727 | Cholesteryl esters in VLDL (UKB data field 23416) | GCST90269513 | 0.11 |
| 7728 | ACE2 levels | GCST90468197 | 0.11 |
| 7729 | IDP dMRI TBSS OD Posterior limb of internal capsule R | GCST90004420 | 0.11 |
| 7730 | FABP1/LGALS4 ratio | GCST90314752 | 0.11 |
| 7731 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320627 | 0.11 |
| 7732 | CPXM1/SPARC ratio | GCST90314222 | 0.11 |
| 7733 | CUZD1 levels | GCST90468919 | 0.11 |
| 7734 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143 | ECGU000143 | 0.11 |
| 7735 | NFX1 levels | GCST90470041 | 0.11 |
| 7736 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T402 | ECGU000402 | 0.11 |
| 7737 | aparc-Desikan rh area superiorparietal | GCST90003135 | 0.11 |
| 7738 | Plasma glycocholenate sulfate* levels in chronic kidney disease | GCST90265291 | 0.11 |
| 7739 | GZMA/IL12A_IL12B ratio | GCST90315009 | 0.11 |
| 7740 | CD93/TNFRSF4 ratio | GCST90313922 | 0.11 |
| 7741 | COQ7 levels | GCST90468831 | 0.11 |
| 7742 | PKLR/UBAC1 ratio | GCST90315660 | 0.11 |
| 7743 | Pulse rate | Arterial stiffness | UKBB00000722 | 0.11 |
| 7744 | Right ventricular stroke volume | GCST90134590 | 0.11 |
| 7745 | Alanine levels | GCST003666 | 0.11 |
| 7746 | rfMRI amplitudes (ICA100 node 12) | GCST90004600 | 0.11 |
| 7747 | Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels | GCST90060295 | 0.11 |
| 7748 | Phosphoglycerides levels | GCST90499265 | 0.11 |
| 7749 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499832 | 0.11 |
| 7750 | Triglycerides to total lipids ratio in very large VLDL | GCST90093027 | 0.11 |
| 7751 | IDP dMRI TBSS MO Posterior limb of internal capsule L | GCST90003971 | 0.11 |
| 7752 | Ever thought that life not worth living | Self-harm behaviours | UKBB00000225 | 0.11 |
| 7753 | aparc-a2009s rh area S-oc-middle+Lunatus | GCST90003427 | 0.11 |
| 7754 | HPCAL1/SERPINB9 ratio | GCST90315079 | 0.11 |
| 7755 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456 | ECGU000456 | 0.11 |
| 7756 | DTI TBSS L3 External capsule R | GCST90384556 | 0.11 |
| 7757 | Breast size | GCST006655 | 0.11 |
| 7758 | FABP1/FABP2 ratio | GCST90314750 | 0.11 |
| 7759 | aseg global volume VentricleChoroid | GCST90002598 | 0.11 |
| 7760 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T204 | ECGU000204 | 0.11 |
| 7761 | TNFSF8 levels | GCST90470923 | 0.11 |
| 7762 | EGFLAM levels | GCST90469084 | 0.11 |
| 7763 | TOR1AIP1 levels | GCST90470935 | 0.11 |
| 7764 | Calcium | Blood biochemistry | UKBB00000114 | 0.11 |
| 7765 | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite level | GCST90616405 | 0.11 |
| 7766 | Body fat percentage | GCST90103752 | 0.11 |
| 7767 | PLIN1 levels | GCST90470258 | 0.11 |
| 7768 | CRACR2A/IRAG2 ratio | GCST90314227 | 0.11 |
| 7769 | Cholesterol in small VLDL (UKB data field 23512) | GCST90269609 | 0.11 |
| 7770 | Phospholipids in small VLDL (UKB data field 23511) | GCST90269608 | 0.11 |
| 7771 | Phospholipid levels in very small VLDL | GCST90132659 | 0.11 |
| 7772 | Concentration of small VLDL particles | GCST90092975 | 0.11 |
| 7773 | Docosahexaenoic acid to total fatty acids percentage | GCST90502285 | 0.11 |
| 7774 | Total lipids in IDL (UKB data field 23524) | GCST90269621 | 0.11 |
| 7775 | Provencibacterium abundance in stool | GCST90032528 | 0.11 |
| 7776 | DNM3 levels | GCST90469022 | 0.11 |
| 7777 | Triglycerides in medium VLDL | GCST90499065 | 0.11 |
| 7778 | SERPINE2 levels | GCST90470597 | 0.11 |
| 7779 | Restless leg syndrome | FING00001255 | 0.11 |
| 7780 | CRIP2/SNCG ratio | GCST90314262 | 0.11 |
| 7781 | HippSubfield lh volume CA3-body | GCST90002680 | 0.11 |
| 7782 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422 | ECGU000422 | 0.11 |
| 7783 | PPP1R2/USP8 ratio | GCST90315723 | 0.11 |
| 7784 | CTSZ levels | GCST90468918 | 0.11 |
| 7785 | Concentration of very small VLDL particles | GCST90500826 | 0.11 |
| 7786 | Saturated fatty acids levels | GCST90502185 | 0.11 |
| 7787 | Triglycerides in IDL (UKB data field 23529) | GCST90269626 | 0.11 |
| 7788 | BA-exvivo rh area BA6 | GCST90003227 | 0.11 |
| 7789 | aparc-pial rh area caudalmiddlefrontal | GCST90003177 | 0.11 |
| 7790 | Excessive vomiting in pregnancy | FING00000523 | 0.11 |
| 7791 | EDN1 levels | GCST90469073 | 0.11 |
| 7792 | Self-reported risk-taking behaviour | GCST006810 | 0.11 |
| 7793 | ADGRG1 levels | GCST90468240 | 0.11 |
| 7794 | SDC1 levels | GCST90470558 | 0.11 |
| 7795 | ThalamNuclei lh volume VPL | GCST90002717 | 0.11 |
| 7796 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501075 | 0.11 |
| 7797 | Intervertebral disc disorders (PheCode 722) | GCST90476237 | 0.11 |
| 7798 | Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccine | GCST90448695 | 0.11 |
| 7799 | BRK1 levels | GCST90468469 | 0.11 |
| 7800 | Hyperplasia of prostate (PheCode 600) | GCST90476153 | 0.11 |
| 7801 | Preeclampsia or other maternal hypertension (maternal genotype effect) | GCST90269904 | 0.11 |
| 7802 | PPY levels | GCST90470309 | 0.11 |
| 7803 | ALDH1A1/RBKS ratio | GCST90313247 | 0.11 |
| 7804 | DTI autoptx L2 ifo l tract | GCST90385178 | 0.11 |
| 7805 | 1-arachidonoylglycerophosphoethanolamine levels | GCST90243808 | 0.11 |
| 7806 | Average diameter for LDL particles | GCST90092889 | 0.11 |
| 7807 | CA2/NSFL1C ratio | GCST90313580 | 0.11 |
| 7808 | CETN2 levels | GCST90468721 | 0.11 |
| 7809 | Free cholesterol in LDL (UKB data field 23421) | GCST90269518 | 0.11 |
| 7810 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276 | ECGU000276 | 0.11 |
| 7811 | Docosahexaenoic acid levels | GCST90501984 | 0.11 |
| 7812 | LEP levels | GCST90012076 | 0.11 |
| 7813 | MMP9/OSM ratio | GCST90315468 | 0.11 |
| 7814 | F-whole food liking (derived food-liking factor) | GCST90094868 | 0.11 |
| 7815 | Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systems | UKBB00000625 | 0.11 |
| 7816 | Triglyceride levels in small LDL | GCST90092966 | 0.11 |
| 7817 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470 | ECGA000470 | 0.11 |
| 7818 | Calculus of kidney | genitourinary | UKBB00000115 | 0.11 |
| 7819 | Mouth/teeth dental problems - Dentures | Mouth | UKBB00000486 | 0.11 |
| 7820 | HSPB1/QDPR ratio | GCST90315089 | 0.11 |
| 7821 | DTI TBSS MD Cingulum hippocampus L | GCST90384609 | 0.11 |
| 7822 | Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivity | GCST90302659 | 0.11 |
| 7823 | CRKL/PLA2G4A ratio | GCST90314271 | 0.11 |
| 7824 | Polycystic ovarian syndrome, consortium definition | FING00001184 | 0.11 |
| 7825 | BCR/ICA1 ratio | GCST90313493 | 0.11 |
| 7826 | HGF/MMP9 ratio | GCST90315056 | 0.11 |
| 7827 | GP6/SCARF1 ratio | GCST90314969 | 0.11 |
| 7828 | Age spots | GCST006096 | 0.11 |
| 7829 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476363 | 0.11 |
| 7830 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133 | ECGU000133 | 0.11 |
| 7831 | Cholesterol in medium VLDL (UKB data field 23505) | GCST90269602 | 0.11 |
| 7832 | IDP dMRI TBSS ICVF Anterior corona radiata L | GCST90004350 | 0.11 |
| 7833 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500949 | 0.11 |
| 7834 | ITGB1BP2/PTPN6 ratio | GCST90315218 | 0.11 |
| 7835 | Nervous feelings | Mental health | UKBB00000495 | 0.11 |
| 7836 | BLVRB/HMBS ratio | GCST90313526 | 0.11 |
| 7837 | Total fatty acid levels | GCST90502211 | 0.11 |
| 7838 | Leg fat percentage left (UKB data field 23115) | GCST90468174 | 0.11 |
| 7839 | Blood cell traits latent factor 6 (red cell (and basophil)) | GCST90559248 | 0.11 |
| 7840 | ABHD14B/SCRN1 ratio | GCST90313145 | 0.11 |
| 7841 | Total fatty acids levels (UKB data field 23442) | GCST90269539 | 0.11 |
| 7842 | NUDT5/TXNRD1 ratio | GCST90315582 | 0.11 |
| 7843 | Nephrotic syndrome | GCST90018664 | 0.11 |
| 7844 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436 | ECGU000436 | 0.11 |
| 7845 | aparc-DKTatlas rh area insula | GCST90003296 | 0.11 |
| 7846 | IgA nephropathy (IgA glomerulonephritis) | FING00000660 | 0.11 |
| 7847 | SMNDC1 levels | GCST90470681 | 0.11 |
| 7848 | EDAR/IPCEF1 ratio | GCST90314578 | 0.11 |
| 7849 | Gastrointestinal issues (confirmatory factor analysis Factor 31) | GCST90309365 | 0.11 |
| 7850 | aparc-a2009s lh area G-precuneus | GCST90003326 | 0.11 |
| 7851 | ICAM1/SELE ratio | GCST90315116 | 0.11 |
| 7852 | RILPL2 levels | GCST90470470 | 0.11 |
| 7853 | Monounsaturated fatty acid levels | GCST90502029 | 0.11 |
| 7854 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500791 | 0.11 |
| 7855 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499564 | 0.11 |
| 7856 | T1 FreeSurfer a2009s rh S temporal sup area | GCST90384962 | 0.11 |
| 7857 | Takes medication for gout? | GCST90476382 | 0.11 |
| 7858 | EIF1AX levels | GCST90241120 | 0.11 |
| 7859 | Ceramide (d17:1/24:0) levels | GCST90024033 | 0.11 |
| 7860 | ITGB1BP2/MED18 ratio | GCST90315213 | 0.11 |
| 7861 | BACH1/HEXIM1 ratio | GCST90313440 | 0.11 |
| 7862 | Flat foot [pes planus] (acquired) | FING00000545 | 0.11 |
| 7863 | Monocyte percentage of white cells | GCST004609 | 0.11 |
| 7864 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396 | ECGU000396 | 0.10 |
| 7865 | REST UKBBICA NODEamps25 0006 | GCST90385489 | 0.10 |
| 7866 | CFD levels | GCST90468725 | 0.10 |
| 7867 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T403 | ECGU000403 | 0.10 |
| 7868 | IDP dMRI TBSS FA Genu of corpus callosum | GCST90003879 | 0.10 |
| 7869 | aparc-pial rh area TotalSurface | GCST90003174 | 0.10 |
| 7870 | CASP8/PPP3R1 ratio | GCST90313654 | 0.10 |
| 7871 | CLEC4D/HGF ratio | GCST90314110 | 0.10 |
| 7872 | DNA methylation GrimAge acceleration | GCST90014288 | 0.10 |
| 7873 | Biological Mother: Coronary Artery / Coronary Heart Disease | GCST90475488 | 0.10 |
| 7874 | Waist circumference | GCST90103753 | 0.10 |
| 7875 | Cholesterol in Large LDL | GCST90497919 | 0.10 |
| 7876 | CD63/CLEC1B ratio | GCST90313863 | 0.10 |
| 7877 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392 | ECGU000392 | 0.10 |
| 7878 | aparc-pial lh area postcentral | GCST90003162 | 0.10 |
| 7879 | Major depressive disorder | GCST009979 | 0.10 |
| 7880 | Cholesteryl esters to total lipids ratio in medium LDL | GCST90092907 | 0.10 |
| 7881 | Cholesteryl esters in IDL (UKB data field 23527) | GCST90269624 | 0.10 |
| 7882 | IDP dMRI TBSS MD Cerebral peduncle L | GCST90004042 | 0.10 |
| 7883 | Mean platelet volume during second trimester of pregnancy | GCST90302230 | 0.10 |
| 7884 | Treatment/medication code - ibuprofen | Medications | UKBB00000847 | 0.10 |
| 7885 | LILRA5 levels | GCST90469774 | 0.10 |
| 7886 | Left-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302660 | 0.10 |
| 7887 | Phospholipids to Total Lipids in Very Small VLDL percentage | GCST90500866 | 0.10 |
| 7888 | IDP T1 FAST ROIs V cerebellum VIIb | GCST90002576 | 0.10 |
| 7889 | Lesion of plantar nerve | FING00000720 | 0.10 |
| 7890 | FLT4/KDR ratio | GCST90314861 | 0.10 |
| 7891 | Phospholipids to Total Lipids in Medium VLDL percentage | GCST90499043 | 0.10 |
| 7892 | CST6/FABP9 ratio | GCST90314301 | 0.10 |
| 7893 | FUT3_FUT5/LILRA2 ratio | GCST90314889 | 0.10 |
| 7894 | Docosahexaenoic acid to total fatty acids percentage | GCST90502280 | 0.10 |
| 7895 | OLR1/OSM ratio | GCST90315583 | 0.10 |
| 7896 | X-21441 levels | GCST90200581 | 0.10 |
| 7897 | AmygNuclei rh volume Medial-nucleus | GCST90002663 | 0.10 |
| 7898 | aparc-DKTatlas rh area superiorparietal | GCST90003292 | 0.10 |
| 7899 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270 | ECGU000270 | 0.10 |
| 7900 | Volume of right lateral nucleus | GCST90474922 | 0.10 |
| 7901 | Plasma cystathionine levels in chronic kidney disease | GCST90264974 | 0.10 |
| 7902 | T1 FreeSurfer aseg Brain-Stem | GCST90384149 | 0.10 |
| 7903 | EBAG9/TBCC ratio | GCST90314568 | 0.10 |
| 7904 | Statin medication | FING00001331 | 0.10 |
| 7905 | Docosahexaenoic acid to total fatty acids percentage | GCST90497268 | 0.10 |
| 7906 | Right-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302774 | 0.10 |
| 7907 | WNT9A levels | GCST90471079 | 0.10 |
| 7908 | CNTNAP2 levels | GCST90468808 | 0.10 |
| 7909 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274 | ECGA000274 | 0.10 |
| 7910 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90025434 | 0.10 |
| 7911 | Omega-3 fatty acids to total fatty acids percentage | GCST90502448 | 0.10 |
| 7912 | SERPINB1/SERPINB6 ratio | GCST90315826 | 0.10 |
| 7913 | EREG/HBEGF ratio | GCST90314702 | 0.10 |
| 7914 | CD40LG/EGF ratio | GCST90313819 | 0.10 |
| 7915 | HippSubfield lh volume subiculum-head | GCST90002671 | 0.10 |
| 7916 | Personal history of medical treatment | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000643 | 0.10 |
| 7917 | APOB levels | GCST90497130 | 0.10 |
| 7918 | CLEC1B/DIABLO ratio | GCST90314087 | 0.10 |
| 7919 | Pain medicine use during menstruation | GCST006637 | 0.10 |
| 7920 | Cholesteryl Esters in LDL | GCST90498363 | 0.10 |
| 7921 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T140 | ECGU000140 | 0.10 |
| 7922 | GLOD4/MIF ratio | GCST90314939 | 0.10 |
| 7923 | CAPN3 levels | GCST90468538 | 0.10 |
| 7924 | PDGFRA levels | GCST90421093 | 0.10 |
| 7925 | Omega-3 fatty acid levels | GCST90502441 | 0.10 |
| 7926 | Citrate levels (UKB data field 23473) | GCST90269570 | 0.10 |
| 7927 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502043 | 0.10 |
| 7928 | Total esterified cholesterol levels (UKB data field 23415) | GCST90269512 | 0.10 |
| 7929 | CD55/PTGDS ratio | GCST90313847 | 0.10 |
| 7930 | Triglyceride levels in small HDL | GCST90092954 | 0.10 |
| 7931 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450 | ECGU000450 | 0.10 |
| 7932 | Diastolic blood pressure, manual reading | Blood pressure | UKBB00000180 | 0.10 |
| 7933 | Cholesteryl Esters in Medium LDL | GCST90498739 | 0.10 |
| 7934 | Free cholesterol in IDL (UKB data field 23528) | GCST90269625 | 0.10 |
| 7935 | BSG/IL12A_IL12B ratio | GCST90313532 | 0.10 |
| 7936 | Urea | Blood biochemistry | UKBB00000885 | 0.10 |
| 7937 | 1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels | GCST90199652 | 0.10 |
| 7938 | estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | GCST90475282 | 0.10 |
| 7939 | X-24328 levels | GCST90200624 | 0.10 |
| 7940 | Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302746 | 0.10 |
| 7941 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T123 | ECGU000123 | 0.10 |
| 7942 | Number of sexual partners in opposite-sex sexual behavior | GCST90026482 | 0.10 |
| 7943 | Urea levels (UKB data field 30670) | GCST90468108 | 0.10 |
| 7944 | Free cholesterol to total lipids ratio in very small VLDL | GCST90093033 | 0.10 |
| 7945 | Red cell distribution width | GCST90002404 | 0.10 |
| 7946 | CD22/FOLR2 ratio | GCST90313758 | 0.10 |
| 7947 | HBEGF levels | GCST90469433 | 0.10 |
| 7948 | Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302748 | 0.10 |
| 7949 | Common executive function | GCST90503115 | 0.10 |
| 7950 | Plasma methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265508 | 0.10 |
| 7951 | Happiness | Mental health | UKBB00000305 | 0.10 |
| 7952 | NBN levels | GCST90470002 | 0.10 |
| 7953 | Visual disturbances | FING00001437 | 0.10 |
| 7954 | DAB2/NCK2 ratio | GCST90314367 | 0.10 |
| 7955 | Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093049 | 0.10 |
| 7956 | ENO2/MGLL ratio | GCST90314663 | 0.10 |
| 7957 | Total phospholipids in lipoprotein particles (UKB data field 23411) | GCST90269508 | 0.10 |
| 7958 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | GCST90269711 | 0.10 |
| 7959 | 3-methyl-2-oxovalerate levels | GCST90243485 | 0.10 |
| 7960 | TGFBI/VASN ratio | GCST90315915 | 0.10 |
| 7961 | X-11550 levels | GCST90243648 | 0.10 |
| 7962 | ALDH1A1/SORD ratio | GCST90313248 | 0.10 |
| 7963 | Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary Administration | UKBB00000837 | 0.10 |
| 7964 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T208 | ECGU000208 | 0.10 |
| 7965 | T1 FreeSurfer a2009s lh G front sup thickness | GCST90384757 | 0.10 |
| 7966 | IDP dMRI ProbtrackX ICVF ml r | GCST90004393 | 0.10 |
| 7967 | EIF3J levels | GCST90241122 | 0.10 |
| 7968 | DKK3/LTBP2 ratio | GCST90314487 | 0.10 |
| 7969 | Alpha angle | GCST90129635 | 0.10 |
| 7970 | Acute laryngitis and tracheitis | FING00000023 | 0.10 |
| 7971 | PCDH17/TEK ratio | GCST90315606 | 0.10 |
| 7972 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53 | ECGA000053 | 0.10 |
| 7973 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T127 | ECGU000127 | 0.10 |
| 7974 | SERPINA6 levels | GCST90470586 | 0.10 |
| 7975 | Total Ceramide levels | GCST90024578 | 0.10 |
| 7976 | CALCOCO1/MAP3K5 ratio | GCST90313605 | 0.10 |
| 7977 | AXL/IL18BP ratio | GCST90313420 | 0.10 |
| 7978 | F-savoury food liking (derived food-liking factor) | GCST90094833 | 0.10 |
| 7979 | IDP dMRI TBSS ICVF Medial lemniscus L | GCST90004336 | 0.10 |
| 7980 | aparc-DKTatlas lh area rostralmiddlefrontal | GCST90003259 | 0.10 |
| 7981 | What is your weight? (pounds, inv-normal transformed) | GCST90476469 | 0.10 |
| 7982 | Cholesteryl esters in small LDL (UKB data field 23548) | GCST90269645 | 0.10 |
| 7983 | Homeostasis model assessment of beta-cell function | GCST005180 | 0.10 |
| 7984 | Chronic renal failure [CKD] (PheCode 585.3) | GCST90476123 | 0.10 |
| 7985 | Cognitive function (baseline) | GCST90565836 | 0.10 |
| 7986 | Monounsaturated fatty acid levels | GCST90502030 | 0.10 |
| 7987 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T404 | ECGU000404 | 0.10 |
| 7988 | Left ventricular end-diastolic volume | GCST90268124 | 0.10 |
| 7989 | Freckles | GCST006091 | 0.10 |
| 7990 | CEACAM1 levels | GCST90468692 | 0.10 |
| 7991 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T223 | ECGA000223 | 0.10 |
| 7992 | Triglycerides in medium HDL (UKB data field 23571) | GCST90269668 | 0.10 |
| 7993 | ADH4 levels | GCST90468244 | 0.10 |
| 7994 | POMC levels | GCST90470284 | 0.10 |
| 7995 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498847 | 0.10 |
| 7996 | VWC2 levels | GCST90471064 | 0.10 |
| 7997 | Follicle stimulating hormone levels | GCST90483476 | 0.10 |
| 7998 | CEACAM8/RNASE3 ratio | GCST90314004 | 0.10 |
| 7999 | Current tobacco smoking | Smoking | UKBB00000161 | 0.10 |
| 8000 | CD274/EFNA4 ratio | GCST90313768 | 0.10 |